ICUI insider buying and SEC filings, explained
Icu Medical Inc. · CIK 883984
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$4.2M
Planned sales (10b5-1)
$3.5M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 3, 2026 | Planned (10b5-1) | Virginia Ruth Sanzone (VP, General Counsel) sold 4,856 shares at about $168.69 ($819K), marked as a 10b5-1 plan trade. Holdings down 25% to 14,604 shares. | SEC filing Filed Sep 3, 2026 |
| Sep 1, 2026 | Planned (10b5-1) | Brian Michael Bonnell (CFO) sold 6,381 shares at $175.00 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 10% to 56,062 shares. | SEC filing Filed Sep 1, 2026 |
| Aug 31, 2026 | Planned (10b5-1) | Brian Michael Bonnell (CFO) sold 9,307 shares at about $172.79 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 13% to 62,443 shares. | SEC filing Filed Aug 31, 2026 |
| Aug 13, 2026 | Sale | Daniel Woolson (VP, GM-Infusion Capital) sold 5,417 shares at $181.33 ($982K). Holdings down 24% to 17,062 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 13, 2026 |
| Aug 12, 2026 | Sale | Ben Sousa (Chief Information Officer) sold 2,250 shares at $178.32 ($401K). Holdings down 42% to 3,076 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 12, 2026 |
| Aug 11, 2026 | Sale | Christian B. Voigtlander (President / COO) sold 8,929 shares at about $182.93 ($1.6M). Holdings down 19% to 37,377 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 11, 2026 | Sale | Elisha W. Finney (Director) sold 378 shares at about $182.48 ($69K). Holdings down 7% to 4,871 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| May 22, 2026 | Sale | Daniel Woolson (President / COO) sold 2,123 shares at about $132.21 ($281K). Holdings down 9% to 22,479 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 14, 2026 | Sale | Virginia Ruth Sanzone (VP, General Counsel) sold 2,447 shares at $124.08 ($304K). Holdings down 11% to 19,460 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 15, 2026 |
| Nov 25, 2025 | Sale | Daniel Woolson (VP, GM-Infusion Capital) sold 2,897 shares at $152.35 ($441K). Holdings down 20% to 11,297 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 11, 2025 | Sale | Virginia Ruth Sanzone (VP, General Counsel) sold 930 shares at $142.35 ($132K). Holdings down 15% to 5,456 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 12, 2025 |
22 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ICUI in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.